Eyenovia Inc
EYEN6.970USD
+3.999+134.68%
收盤 06/17, 16:00（美東）報價延遲15分鐘
19.73M總市值
虧損本益比TTM
關於 Eyenovia Inc 公司
Eyenovia, Inc. 是一家商業階段的眼科製藥技術公司，正在開發基於其 Optejet 平臺的微劑量陣列打印療法。該公司專注於 Mydcombi（託吡卡胺+苯腎上腺素眼用噴霧劑）的商業化，用於治療散瞳，以及 0.05% 丙酸氯倍他索眼用混懸液，用於減輕眼科手術後的疼痛和炎症。其產品線包括 Mydcombi、丙酸氯倍他索和治療方案 MicroPine 和 MicroLine。Mydcombi 是託吡卡胺-苯腎上腺素的固定組合配方，用於在診斷程序中以及在需要短期瞳孔擴張的情況下誘導散瞳。MicroPine 是其用於治療進行性近視的局部療法，這是一種與眼球病理性軸向延長和鞏膜視網膜拉伸有關的疾病。 MicroLine 是該公司針對老花眼（一種與年齡相關的不可預防的晶狀體硬化）的在研藥物。
公司簡介
公司代碼EYEN
公司名稱Eyenovia Inc
上市日期Jan 25, 2018
成立日期2014
CEOMr. Michael M. Rowe
員工數量13
證券類型Ordinary Share
年結日Jan 25
公司地址295 Madison Ave Ste 2400
城市NEW YORK
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編10017
電話18137669539
網址https://eyenovia.com/
公司代碼EYEN
上市日期Jan 25, 2018
成立日期2014
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Tsontcho Ianchulev, M.D.
Dr. Tsontcho Ianchulev, M.D.
Director
Director
12.78K
+6.38%
Dr. Ellen R. Strahlman, M.D.
Dr. Ellen R. Strahlman, M.D.
Independent Director
Independent Director
1.71K
+81.68%
Mr. Michael M. Rowe
Mr. Michael M. Rowe
President, Chief Executive Officer, Principal Financial Officer, Treasurer, Company Secretary, Director
President, Chief Executive Officer, Principal Financial Officer, Treasurer, Company Secretary, Director
1.37K
-0.07%
Ms. Rachel Jacobson
Ms. Rachel Jacobson
Independent Director
Independent Director
1.30K
+143.63%
Dr. Ram Palanki, Pharm.D.
Dr. Ram Palanki, Pharm.D.
Independent Director
Independent Director
1.24K
+163.89%
Mr. Bren Kern
Mr. Bren Kern
Chief Operating Officer
Chief Operating Officer
31.00
--
Mr. Eric Ribner
Mr. Eric Ribner
Investor Relations
Investor Relations
--
--
Mr. Michael Geltzeiler
Mr. Michael Geltzeiler
Independent Director
Independent Director
--
--
Mr. Charles E. Mather, IV
Mr. Charles E. Mather, IV
Independent Chairman of the Board
Independent Chairman of the Board
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Tsontcho Ianchulev, M.D.
Dr. Tsontcho Ianchulev, M.D.
Director
Director
12.78K
+6.38%
Dr. Ellen R. Strahlman, M.D.
Dr. Ellen R. Strahlman, M.D.
Independent Director
Independent Director
1.71K
+81.68%
Mr. Michael M. Rowe
Mr. Michael M. Rowe
President, Chief Executive Officer, Principal Financial Officer, Treasurer, Company Secretary, Director
President, Chief Executive Officer, Principal Financial Officer, Treasurer, Company Secretary, Director
1.37K
-0.07%
Ms. Rachel Jacobson
Ms. Rachel Jacobson
Independent Director
Independent Director
1.30K
+143.63%
Dr. Ram Palanki, Pharm.D.
Dr. Ram Palanki, Pharm.D.
Independent Director
Independent Director
1.24K
+163.89%
Mr. Bren Kern
Mr. Bren Kern
Chief Operating Officer
Chief Operating Officer
31.00
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 6月3日 週二
更新時間: 6月3日 週二
持股股東
股東類型
持股股東
持股股東
佔比
Avenue Capital Group
15.10%
UBS Financial Services, Inc.
6.91%
Virtu Americas LLC
0.80%
Ianchulev (Tsontcho)
0.44%
Citadel Advisors LLC
0.43%
Other
76.31%
持股股東
持股股東
佔比
Avenue Capital Group
15.10%
UBS Financial Services, Inc.
6.91%
Virtu Americas LLC
0.80%
Ianchulev (Tsontcho)
0.44%
Citadel Advisors LLC
0.43%
Other
76.31%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
15.47%
Investment Advisor
6.97%
Research Firm
0.84%
Individual Investor
0.75%
Hedge Fund
0.43%
Other
75.54%
機構持股
更新時間: 3月3日 週一
更新時間: 3月3日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
142
82.72K
3.48%
-235.24K
2024Q4
145
87.40K
4.18%
-230.58K
2024Q3
143
274.49K
30.78%
+4.44K
2024Q2
142
255.79K
39.17%
+31.25K
2024Q1
131
203.15K
36.02%
-59.46K
2023Q4
121
244.77K
45.33%
+8.04K
2023Q3
122
223.92K
43.30%
+34.30K
2023Q2
116
185.43K
39.56%
+8.82K
2023Q1
83
152.79K
33.61%
-20.71K
2022Q4
82
156.27K
35.26%
-17.49K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Avenue Capital Group
30.62K
1.46%
+23.77K
+347.12%
Dec 31, 2024
Ianchulev (Tsontcho)
12.01K
0.57%
--
--
Dec 02, 2024
Geode Capital Management, L.L.C.
7.22K
0.34%
+242.00
+3.47%
Dec 31, 2024
Mather (Charles E IV)
1.19K
0.06%
-769.00
-39.36%
Dec 02, 2024
Strahlman (Ellen R)
939.00
0.04%
-769.00
-45.02%
Dec 02, 2024
Rowe (Michael M)
1.38K
0.07%
--
--
Dec 02, 2024
查看更多
持股ETF
更新時間: 6月6日 週五
更新時間: 6月6日 週五
機構名稱
佔比
Global X Russell 2000 Covered Call ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Russell 2000 Growth ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
iShares Micro-Cap ETF
0%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 Covered Call ETF
佔比0%
iShares Core S&P Total U.S. Stock Market ETF
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
ProShares UltraPro Russell2000
佔比0%
Proshares Ultra Russell 2000
佔比0%
iShares Russell 2000 ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
Invesco NASDAQ Future Gen 200 ETF
佔比0%
iShares Micro-Cap ETF
佔比0%
ProShares Hedge Replication ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Jan 15, 2025
Merger
80<1
Jan 15, 2025
Merger
80<1
Jan 15, 2025
Merger
80<1
Jan 15, 2025
Merger
80<1
公告日期
類型
比率
Jan 15, 2025
Merger
80<1
Jan 15, 2025
Merger
80<1
Jan 15, 2025
Merger
80<1
Jan 15, 2025
Merger
80<1
